Stock listing
Merck & Company, Inc.
- Ticker
- Cboe Canada: MRK
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Cboe Canada
- Currency
- CAD
About Merck & Company, Inc.
The company is known for its innovative healthcare solutions and commitment to improving patient outcomes. Merck develops a wide range of prescription medicines, vaccines, and biologic therapies.
Latest news from Merck & Company, Inc.
Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic Macular Edema at AAO 2026
Oct 10, 2026
Merck: EMD Electronics Opens New R&D Facility in Wisconsin to Accelerate Advanced Semiconductor M
Oct 2, 2026
Merck to Hold Third-Quarter 2026 Sales and Earnings Conference Call Oct. 29
Oct 1, 2026
Merck's Tulisokibart Met Primary and Key Secondary Endpoints in Phase 2b Study in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
Sep 30, 2026